Atıf İçin Kopyala
KARADAĞ Ö., DALKILIÇ H. E., AYAN G., KÜÇÜKŞAHİN O., KAŞİFOĞLU T., Yilmaz N., ...Daha Fazla
CLINICAL RHEUMATOLOGY, cilt.41, sa.1, ss.85-94, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
41
Sayı:
1
-
Basım Tarihi:
2022
-
Doi Numarası:
10.1007/s10067-021-05893-3
-
Dergi Adı:
CLINICAL RHEUMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.85-94
-
Anahtar Kelimeler:
Anti-TNF, ACR20/50/70, DAPSA28, DAS28, Psoriatic arthritis, Work disability, CERTOLIZUMAB PEGOL, CLINICAL-RESPONSE, DISEASE-ACTIVITY, DOUBLE-BLIND, PHASE-III, GOLIMUMAB, SAFETY, TRIAL, MULTICENTER, ETANERCEPT
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Objectives To understand change in work productivity, activity impairment, quality of life (QoL), and disease activity in patients with psoriatic arthritis (PsA) receiving anti-tumor necrosis factor (anti-TNF) treatment.